Burleson & Company LLC decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 1.3% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 13,712 shares of the company’s stock after selling 182 shares during the quarter. Burleson & Company LLC’s holdings in Colgate-Palmolive were worth $861,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Great Lakes Advisors LLC increased its position in Colgate-Palmolive by 795.0% during the third quarter. Great Lakes Advisors LLC now owns 77,893 shares of the company’s stock worth $5,215,000 after buying an additional 69,190 shares during the period. Carnegie Capital Asset Management LLC increased its position in Colgate-Palmolive by 94.1% during the third quarter. Carnegie Capital Asset Management LLC now owns 56,214 shares of the company’s stock worth $3,556,000 after buying an additional 27,250 shares during the period. Reynders McVeigh Capital Management LLC increased its position in Colgate-Palmolive by 31.3% during the third quarter. Reynders McVeigh Capital Management LLC now owns 10,400 shares of the company’s stock worth $696,000 after buying an additional 2,480 shares during the period. Vanguard Group Inc. increased its position in Colgate-Palmolive by 1.0% during the third quarter. Vanguard Group Inc. now owns 73,520,894 shares of the company’s stock worth $4,922,224,000 after buying an additional 734,860 shares during the period. Finally, Matthew Goff Investment Advisor LLC acquired a new position in Colgate-Palmolive during the third quarter worth approximately $303,000. 75.10% of the stock is currently owned by institutional investors.
Shares of Colgate-Palmolive stock traded down $0.54 during trading on Thursday, reaching $62.54. The company’s stock had a trading volume of 25,327 shares, compared to its average volume of 4,783,515. The company has a debt-to-equity ratio of 64.85, a current ratio of 1.11 and a quick ratio of 0.77. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $77.91. The company has a market cap of $54.71 billion, a PE ratio of 21.85, a price-to-earnings-growth ratio of 3.10 and a beta of 0.76.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 26th. The company reported $0.72 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 12,004.60% and a net margin of 13.55%. The firm had revenue of $3.85 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same period in the previous year, the business earned $0.73 earnings per share. The company’s revenue for the quarter was down 3.2% compared to the same quarter last year. On average, equities research analysts anticipate that Colgate-Palmolive will post 2.96 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Thursday, November 15th. Investors of record on Friday, October 19th were paid a $0.42 dividend. The ex-dividend date was Thursday, October 18th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.69%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.54%.
In related news, VP Philip G. Shotts sold 462 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total value of $30,977.10. Following the sale, the vice president now directly owns 41,250 shares in the company, valued at $2,765,812.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Henning I. Jakobsen sold 1,015 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, September 11th. The shares were sold at an average price of $67.05, for a total value of $68,055.75. Following the completion of the sale, the chief financial officer now owns 36,193 shares in the company, valued at $2,426,740.65. The disclosure for this sale can be found here. 1.02% of the stock is owned by insiders.
Several research analysts have commented on CL shares. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Monday, October 29th. Argus reissued a “buy” rating and issued a $75.00 target price (up previously from $72.00) on shares of Colgate-Palmolive in a report on Tuesday, September 18th. Citigroup dropped their target price on Colgate-Palmolive from $68.00 to $63.00 and set a “hold” rating on the stock in a report on Monday, October 29th. Wells Fargo & Co dropped their target price on Colgate-Palmolive from $62.00 to $58.00 and set a “market perform” rating on the stock in a report on Monday, October 29th. Finally, SunTrust Banks lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their target price for the company from $80.00 to $65.00 in a report on Friday, October 26th. Three analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $68.20.
ILLEGAL ACTIVITY NOTICE: “Colgate-Palmolive (CL) Shares Sold by Burleson & Company LLC” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/12/06/colgate-palmolive-cl-shares-sold-by-burleson-company-llc.html.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Featured Story: Consumer Price Index (CPI)
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.